| Literature DB >> 28383484 |
Tomohiko Tomura1, Shiori Nagashima2, Satoshi Yamazaki3, Takashi Iizuka4, Ryosuke Fudou5, Makoto Ojika6.
Abstract
Three new compounds, enhygromic acid (1) and deoxyenhygrolides A (2) and B (3), were isolated from a marine myxobacterium, Enhygromyxa sp. Compound 1 was found to be an acrylic acid derivative with a rare polycyclic carbon skeleton, decahydroacenaphthylene, by spectroscopic analyses. Compounds 2 and 3 were deoxy analogs of the known γ-alkylidenebutenolides, enhygrolides. Compound 1 exhibited cytotoxicity against B16 melanoma cells and anti-bacterial activity against Bacillus subtilis, and enhanced the NGF-induced neurite outgrowth of PC12 cells.Entities:
Keywords: NGF-enhancing activity; antibacterial activity; cytotoxicity; diterpene; marine myxobacterium
Mesh:
Substances:
Year: 2017 PMID: 28383484 PMCID: PMC5408255 DOI: 10.3390/md15040109
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of 1–3.
Figure 2Phylogenetic tree of myxobacteria. Neighbor-joining (NJ) tree based on 16S rRNA gene sequences shows the positions of Enhygromyxa sp. SNB-1 (tentative name: E. niigataensis, top) in the order Myxococcales. The bar represents 20 nt substitutions per 1000 sites. Bootstrap values (>50%) based on 1000 replications are shown at branch nodes. Three suborders in the order Myxococcales are also indicated. The two species at the bottom were used as outgroups.
1H (600 MHz) and 13C (150 MHz) NMR spectroscopic data for enhygromic acid (1) in DMSO-d6.
| Position | δC, Type | δH ( | HMBC |
|---|---|---|---|
| 1 | 170.2, C | ||
| 2 | 127.2 (br), C | ||
| 3 | 145.9 (br), CH | 7.27, s | 4 |
| 4 | 52.2, C | ||
| 5 | 46.7, CH | 2.81, brd (7.1) | 4 |
| 6 | 148.9, C | ||
| 7a | 35.3, CH2 | 2.08, m | |
| 7b | 2.39, dt (13.1, 3.0) | ||
| 8a | 21.7, CH2 | 1.36, m | |
| 8b | 1.55 m | ||
| 9 | 45.2, CH | 2.04, m | 4 |
| 10 | 31.7, CH | 1.55, m | |
| 11a | 29.4, CH2 | 1.09, m | |
| 11b | 1.42, m | ||
| 12 | 21.6, CH2 | 1.43, m; 1.45, m | 4 |
| 13 | 46.9, CH | 1.49, dd (12.7, 3.4) | |
| 14 | 35.6, C | ||
| 15a | 40.6, CH2 | 1.35, m | 4 |
| 15b | 1.92, m | ||
| 16a | 108.1, CH2 | 4.76, s | 5, 6, 7 |
| 16b | 4.85, d (1.5) | ||
| 17 | 19.6, CH3 | 0.76, d (6.9) | |
| 18 | 32.6, CH3 | 1.00, s | 13, 14 |
| 19 | 26.7, CH3 | 0.86, s | 14, 15 |
| 20 | 14.7, CH3 | 1.92, s | 1, 2, 3 |
HMBC correlations are from proton(s) started to the indicated carbon.
Figure 3Two-dimensional NMR correlations for 1. (A) DQF-COSY (bold bonds) and HMBC correlations (arrows). (B) Key NOESY correlations (double-headed red arrows).
Figure 4Two energy-minimized conformers A and B of 1.
Figure 5CD spectrum and the lowest energy conformer A of 1.
1H (400 MHz) and 13C (100 MHz) NMR spectroscopic data for deoxyenhygrolides A (2) and B (3) in C6D6.
| Deoxyenhygrolide A (2) | Deoxyenhygrolode B (3) | |||||
|---|---|---|---|---|---|---|
| Position | δC, Type | δH ( | HMBC | δC, Type | δH ( | HMBC |
| 1 | 169.8, C | 169.3, C | ||||
| 2 | 127.5, C | 132.5, C | ||||
| 3 | 152.0, C | 149.6, C | ||||
| 4 | 149.2, C | 150.2, C | ||||
| 5 | 109.0, CH | 5.70, s | 3, 4, 6, 7, 11 | 113.8, CH | 6.58, s | 3, 4, 6, 7, 11 |
| 6 | 133.8, C | 133.7, C | ||||
| 7, 11 | 130.7, CH | 7.74, d (7.5) | 129.5, CH | 6.82, m | ||
| 8, 10 | 129.0, CH | 7.12, t (7.5) | 128.3, CH | 6.96, m | ||
| 9 | 128.7, CH | 7.01, t (7.5) | 128.0, CH | 6.96, m | ||
| 12 | 30.1, CH2 | 3.51, s | 1, 2, 3, 13, 14, 18 | 30.2, CH2 | 3.56, s | 1, 2, 3, 13, 14, 18 |
| 13 | 138.4, C | 138.4, C | ||||
| 14, 18 | 128.9, CH | 7.18, d (7.5) | 128.9, CH | 7.25, d (7.5) | ||
| 15, 17 | 128.9, CH | 7.10, t (7.5) | 128.9, CH | 7.12, t (7.2) | ||
| 16 | 126.8, CH | 7.02, t (7.5) | 126.9, CH | 7.02, t (7.4) | ||
| 19 | 33.6, CH2 | 1.92, d (7.4) | 2, 3, 4 | 34.8, CH2 | 2.00, d (7.1) | 2, 3, 4 |
| 20 | 29.1, CH | 1.55, non (6.6) | 3 | 28.3, CH | 1.07, non (6.8) | 3 |
| 21, 22 | 22.6, CH3 | 0.62, d (6.6) | 22.0, CH3 | 0.33, d (6.6) | ||
HMBC correlations are from proton(s) started to the indicated carbon.
Figure 6Key correlations in two-dimensional NMR spectra of 2 and 3.
Figure 7Bioactivities of enhygromic acid (1). (A) Cytotoxicity of 1 (open triangles) and paclitaxel (open circles, dotted line) against the B16 melanoma cells. (B) Enhancing activity of NGF-induced neurite outgrowth of PC12 cells.
Figure 8A putative biosynthetic pathway for enhygromic acid (1). The first step would be the cyclization of farnesyl diphosphate (FPP) to α-humulene (Route a) or geranylgeranyl diphosphate (GGPP) to a dimethylallylhumulene derivative (Route b), which are converted to the common cation intermediate I and led to 1 via a series of steps.